Cargando…

Acute Exacerbation of COPD

Acute exacerbations of COPD involve increased symptoms such as cough, dyspnea and sputum production. These exacerbations are associated with increased mortality as well as decline in lung function. Non-invasive positive-pressure ventilation (NIPPV) is the preferred method of ventilatory support in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Lief, Lindsay, McSparron, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121203/
http://dx.doi.org/10.1007/978-3-030-26710-0_22
_version_ 1783515150189330432
author Lief, Lindsay
McSparron, Jakob
author_facet Lief, Lindsay
McSparron, Jakob
author_sort Lief, Lindsay
collection PubMed
description Acute exacerbations of COPD involve increased symptoms such as cough, dyspnea and sputum production. These exacerbations are associated with increased mortality as well as decline in lung function. Non-invasive positive-pressure ventilation (NIPPV) is the preferred method of ventilatory support in respiratory failure secondary to AECOPD. NIPPV reduces work of breathing, improves oxygenation and ventilation and decreases both mortality and the risk of invasive ventilation. Other therapies for AECOPD include inhaled bronchodilators and systemic glucocorticoids. Antibiotics are recommended for severe exacerbations. Future areas of interest in treatment for AECOPD include utilization of biomarkers and extracorporeal carbon dioxide removal.
format Online
Article
Text
id pubmed-7121203
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-71212032020-04-06 Acute Exacerbation of COPD Lief, Lindsay McSparron, Jakob Evidence-Based Critical Care Article Acute exacerbations of COPD involve increased symptoms such as cough, dyspnea and sputum production. These exacerbations are associated with increased mortality as well as decline in lung function. Non-invasive positive-pressure ventilation (NIPPV) is the preferred method of ventilatory support in respiratory failure secondary to AECOPD. NIPPV reduces work of breathing, improves oxygenation and ventilation and decreases both mortality and the risk of invasive ventilation. Other therapies for AECOPD include inhaled bronchodilators and systemic glucocorticoids. Antibiotics are recommended for severe exacerbations. Future areas of interest in treatment for AECOPD include utilization of biomarkers and extracorporeal carbon dioxide removal. 2019-07-24 /pmc/articles/PMC7121203/ http://dx.doi.org/10.1007/978-3-030-26710-0_22 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Lief, Lindsay
McSparron, Jakob
Acute Exacerbation of COPD
title Acute Exacerbation of COPD
title_full Acute Exacerbation of COPD
title_fullStr Acute Exacerbation of COPD
title_full_unstemmed Acute Exacerbation of COPD
title_short Acute Exacerbation of COPD
title_sort acute exacerbation of copd
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121203/
http://dx.doi.org/10.1007/978-3-030-26710-0_22
work_keys_str_mv AT lieflindsay acuteexacerbationofcopd
AT mcsparronjakob acuteexacerbationofcopd